Yardstick Research tear-sheet / CX cohort

Methodology · how we score · rubric weights in plain sight · vendors received this sheet seven days before publication and could flag factual errors, never rankings

Loyal-Health

Identity

• Founded: 2015 in Atlanta, GA. [VENDOR-CLAIMED + THIRD-PARTY corroboration - https://loyalhealth.com/about-us/, https://www.linkedin.com/company/loyal-health]
• HQ: 756 W Peachtree St NW, Suite 725, Atlanta, GA 30308. [THIRD-PARTY - https://www.linkedin.com/company/loyal-health, https://www.zoominfo.com/c/loyal-health-inc/447257827]
• Legal entity: Loyal Health, Inc., d/b/a Loyal. Product is the "Care Activation Platform."
• Funding: ~$46M total. Series B $33.5M, July 22, 2024. Series A $12.5M, 2020. [THIRD-PARTY - https://www.crunchbase.com/funding_round/loyal-series-b--fe21ab8d, https://loyalhealth.com/about-us/]
• Headcount: LinkedIn shows 225 employees with the company-size band 51-200 (fields disagree; operative read is the 200-250 range). [THIRD-PARTY - https://www.linkedin.com/company/loyal-health]
• Leadership:
• Nanette Oddo (CEO) - joined at the July 2024 Series B leadership refresh; previously President & CEO of Truveris
• Austin Pauls (CFO) - June 2023
• Lauren Struck (COO) - July 2023
• Chad Mallory (Founder; no longer CEO)
• [VENDOR-CLAIMED - https://loyalhealth.com/about-us/]
• Recent news (last 12 months):
• March 27, 2025 - VHHA Solutions patient-engagement partnership. [VENDOR-CLAIMED - https://www.vhha.com/pressroom/vhha-solutions-enters-partnership-with-loyal-health-a-leading-health-system-patient-engagement-solution-vendor/]
• August 12, 2024 - UChicago Medicine directory listings customer win. [VENDOR-CLAIMED]
• July 31, 2024 - MEDITECH integration. [VENDOR-CLAIMED]
• July 31, 2024 - Samaritan Medical Center directory management. [VENDOR-CLAIMED]
• July 22, 2024 - $33.5M Series B; CEO transition to Nanette Oddo. [THIRD-PARTY - https://www.crunchbase.com/funding_round/loyal-series-b--fe21ab8d]
• June 26, 2024 - TX-RAMP Level 2 (chatbot). Not on live trust page as of 2026-05-24. [VENDOR-CLAIMED]
• June 4, 2024 - Oracle Healthcare Marketplace listing. [VENDOR-CLAIMED]
• Latent risk: CEO transition mid-2024 (Chad Mallory to Nanette Oddo at Series B close). ~12 months into the new chapter; roadmap-continuity risk worth flagging for any 3+ year contract. [VENDOR-CLAIMED]
• Archetype: Healthcare-vertical patient-experience platform. Sits in the digital-front-door / patient-engagement cluster (Kyruus, Phreesia, Relatient, WELL Health, Artera, Innovaccer-the-CRM-side). Adjacent to but distinct from horizontal CX-AI vendors (Decagon, Sierra, Ada, Intercom Fin, Maven AGI).

Cohort-fit framing (read before the score)

Loyal sits in the cx cohort on the healthcare-vertical side. The cohort is dominated by horizontal CX-AI vendors that ship voice + SMS + email + social channels by default, publish foundation LLMs and safety guardrails, and chase deflection-rate benchmarks across DTC retail, fintech, and B2B SaaS. Loyal optimized differently: deep EHR integration, real action depth inside a US-health-system workflow (book into the EHR, run HRAs, transfer to live human), broad customer roster of named health systems on multi-year multi-module renewals.

The rubric is the same for any cx vendor. The seven dims (integration + accuracy, resolution depth, channel breadth, hallucination + safety, cost economics, time-to-value, brand voice + governance) measure what they measure; Loyal's strengths land on integration breadth (4 major EHRs) and on real write-action depth (appointment booking is a write, not an answer). Its constraints land on channel breadth (no voice / SMS / email / social), safety methodology (no published guardrails, no LLM disclosed), pricing transparency (quote-only, /pricing 404), and brand-voice customization (visual whitelabel only).

For a US-health-system marketing or patient-access leader, Loyal is a real contender against Kyruus, Phreesia, Relatient, WELL Health, Artera, and the patient-experience side of Innovaccer. For a horizontal CX buyer (retail, fintech, B2B SaaS, prosumer), Loyal is not in consideration. The score below is the rubric working as designed against a vertical-specialty vendor.

Total score: 36 / 100 (pre-penalty); ~33 headline_score (with -3 soft pricing-transparency penalty)

• Stage fit:
• Foundation (<40 readiness): no - sales-led enterprise contract; customer roster starts at $250M+ health systems. Foundation-stage buyers (single hospital, FQHC, urgent-care chain) are not the target.
• Pilot (40-59): conditional - if the Pilot is "deploy a chatbot on the health-system website that books appointments into the EHR," Loyal can do it. If the Pilot is "stand up multi-channel CX with voice + SMS + email + social and prove a deflection-rate benchmark," Loyal cannot.
• Scale (60-79): conditional - Loyal is genuinely strong at Scale for the digital-front-door frame (multi-year multi-module deployments at PeaceHealth, Renown, UChicago Medicine, MD Anderson are the evidence). Scale buyers whose top priority is horizontal CX breadth across channels and published safety methodology should look at horizontal cx peers instead.
• Optimization (80+): no - the Optimization-stage cx buyer is benchmarking deflection rate, containment rate, agent-time-saved, and CSAT against published peer-set numbers. Loyal does not publish on any of those axes.
• One-line verdict: Healthcare-vertical CX platform with strong EHR integration and real action depth inside a health-system workflow, scored against a horizontal CX-AI rubric where the channel-breadth, safety-methodology, and benchmark-publication dims it does not address weigh against it. A real fit for US health systems; not a horizontal CX replacement.

Headline numbers

Dimension scores

Pricing detail

• Pricing model: Custom enterprise contracts. No per-seat, per-bed, per-conversation, per-provider-record, or per-patient anchor published anywhere. - https://loyalhealth.com/
• Published anchors: One ROI calculator for the chatbot product (buyer-supplied inputs; no Loyal-published unit price grounds the calculation). - https://loyalhealth.com/knowledge_base/calculating-roi-for-your-chatbot-investment/
• CTAs across every product page: "Request a Demo," "Talk to Sales," "Get Started." - https://loyalhealth.com/platform/
• Pricing transparency penalty: soft. /pricing returns HTTP 404; never observed published; no Wayback snapshot available in our research window. - https://loyalhealth.com/

Integrations

• EHR (patient-facing scheduling / MyChart handoff / provider-directory write-back): Epic, Cerner / Oracle Health, athenahealth, MEDITECH. - https://loyalhealth.com/chat/, https://www.businesswire.com/news/home/20240604302737/en/Loyal-Now-Available-on-Oracle-Healthcare-Marketplace
• Directory / third-party listings sync: Google Business Profile, Bing Places, other third-party directory platforms. - https://loyalhealth.com/platform/
• CRM delivery channels: Email, SMS (CRM-side - not surfaced as conversational channels in the chatbot). - https://loyalhealth.com/platform/
• Native CRM (no Salesforce / HubSpot / Zendesk bridge): Loyal ships an in-house CRM, no external CRM connector documented. - https://loyalhealth.com/platform/
• FHIR R4 / SMART on FHIR conformance: Not published.
• Cross-cohort native peer integrations (cx): None documented. integrates_with: [].

Editorial assessment

Loyal is a credible healthcare-vertical patient-experience platform - a Care Activation Platform sitting in the digital-front-door cluster alongside Kyruus, Phreesia, Relatient, WELL Health, Artera, and the patient-experience side of Innovaccer. The product portfolio is broad and coherent within the healthcare frame (Provider Data Management, Care Search, Scheduling, Chat, HRAs, CRM, Directory Listings, Ratings + Reviews, Review Response, Review Boost). The customer roster is genuinely strong (PeaceHealth, Renown, Novant, MD Anderson, UChicago Medicine, Summit Health, Lifepoint, Virtua, Ardent, Frederick) and multi-year multi-module renewals are evidence that the digital-front-door bet pays off for the named buyers.

Inside the cx cohort, Loyal is the vertical-specialty type. The rubric scores integration breadth at 25%, resolution depth at 20%, channel breadth at 15%, hallucination + safety guardrails at 15%, cost economics at 10%, time-to-value at 10%, and brand-voice governance at 5%. Loyal's strengths concentrate on the integration-and-actions axes: four major EHR connectors is real breadth for a healthcare-vertical CX vendor; booking appointments directly into the EHR through the chatbot is genuine write-action depth that exceeds Q-and-A. Those are not common capabilities, and the 2/4 raws on data_integration_accuracy and resolution_depth are honest mid-band scores.

The rubric's constraints fall on the dims horizontal CX-AI peers optimize for. Channel breadth scores 1/4 because Loyal does not offer voice, SMS, email, or social channels - web + mobile + MyChart + Google is genuine but narrow against a cohort that treats voice + SMS + email + social as table stakes. Hallucination + safety guardrails scores 1/4 because Loyal publishes neither a foundation LLM nor a safety methodology - and that gap is materially larger for healthcare CX than for general-consumer CX because the chatbot's virtual-triage claim is patient-safety-relevant with no published validation. Cost economics scores 1/4 on absolute-cost-evidence-only grounds (multi-year renewals at named health systems are a cost-value signal but not an absolute anchor). Time-to-value scores 1/4 because the deployment pattern is multi-year phased and no published timeline anchor exists. Brand-voice governance scores 1/4 because customization is visual whitelabel only with no persona / tone system.

The headline score of approximately 33 (36.25 pre-penalty minus 3 for soft pricing transparency) is the rubric working as designed against a vertical-specialty vendor whose optimization differs from horizontal cx peers. The score is not a category error - the founder-applied placement in cx is the right place for Loyal in the catalog because it does run a real CX surface, just one optimized for healthcare-system depth rather than horizontal-channel breadth. Buyers reading this tear sheet should see a vendor with genuine strengths on the EHR-integration-and-action axes and real ceilings on the channel-breadth-and-safety-methodology axes, and decide based on which set the buyer's procurement actually weighs.

Best-fit buyer: a 5-hospital-plus US health system, marketing or patient-access leadership owns the digital front door, willing to procure a vertical-specialty bundle that handles directory + scheduling + chat + CRM + reputation inside one contract rather than stitching the same modules from Kyruus + Press Ganey + Phreesia. Worst-fit buyer: anyone outside US health systems, or a healthcare buyer whose top priority is voice / SMS / email / social channels, multi-language, foundation-LLM transparency, or published safety methodology. When to revisit: (1) if Loyal ships voice or SMS as a first-party channel (channel_breadth lifts directly); (2) if Loyal publishes the foundation LLM behind the chatbot + a safety / guardrail methodology (hallucination_safety_guardrails lifts directly); (3) if Loyal publishes customer-named deflection / containment rates (resolution_depth lifts toward 3/4); (4) if Loyal publishes a HITRUST CSF certification (security posture tightens for healthcare-regulated buyers); (5) if Loyal opens published pricing on /pricing the transparency penalty drops to none.

Layer 4 stack-rank fields

layer4_fields:
  size_fit_min_revenue: 250
  size_fit_max_revenue: 10000
  ai_native_score: 25
  integrates_with: []

Right-of-reply gaps

1. Channel roadmap - does Loyal plan to add voice / IVR, SMS, email auto-response, or social channels (Facebook / WhatsApp / Instagram DM) to the chat product? On what timeline?
2. Foundation LLM disclosure - what underlying language model(s) power the Loyal chatbot, Care Search NLP, and any CRM-side AI? OpenAI, Anthropic, Google, Cohere, or a proprietary fine-tuned model? Does the answer differ across the three surfaces?
3. Hallucination + safety methodology - does Loyal publish (or share under NDA) a safety taxonomy, escalation rubric, citation grounding policy, and prompt-injection defense for the chatbot? When does the bot automatically hand off to a live human?
4. Virtual triage clinical validation - has the triage logic been validated against a published clinical-evidence cohort? Sensitivity / specificity numbers for life-threatening-symptom escalation?
5. Customer-published deflection / containment rate - across the named customer base, what is the typical chatbot deflection or containment rate? Is there a customer willing to be cited with a number?
6. Multi-language support - does Loyal support Spanish for the chatbot? Other languages? First-party or via third-party translation?
7. Persona / tone customization - can buyers shape the bot's voice and tone beyond visual whitelabel? Is there a persona editor, style toggle, brand-voice prompt input, or per-segment persona switching?
8. HITRUST certification status - r2, e1, i1, or none? If none, is HITRUST on the 12-month security roadmap?
9. PHI training opt-out default - in the standard Loyal Business Associate Agreement, is customer PHI excluded from any AI model training (proprietary or third-party) by default, or does the buyer have to negotiate it?
10. Time-to-value anchor - for a 5-hospital regional health system standing up the chatbot module, typical time-to-first-conversation (weeks)? Time-to-full-deployment across PDM + Scheduling + Chat + CRM (months)?
11. Pricing anchors - typical contract size for a 5-hospital regional health system implementing the full platform? Per-bed, per-provider-record, per-patient, or per-conversation unit price?
12. CEO transition narrative - 12 months into the Nanette Oddo era - what has changed in product roadmap or go-to-market focus?
13. Employee headcount - LinkedIn shows 225 with size band 51-200. Current FTE headcount as of Q1 2026?